A New Therapeutic Target: Clec4a2
碩士 === 國立成功大學 === 生物化學研究所 === 98 === Cancer immunotherapy, contrasted with traditional tumor therapy, is a new strategy to give rise to the immune response of patients oneself and destroy the tumor cells without the unwanted side-effects. One of the fast and efficient approaches of cancer immunother...
Main Authors: | Jia-RongLee, 李嘉蓉 |
---|---|
Other Authors: | Ming-Derg Lai |
Format: | Others |
Language: | zh-TW |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/55553414827725268346 |
Similar Items
-
CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment
by: Yinjiang Zhang, et al.
Published: (2021-08-01) -
An evaluation of the tumour endothelial marker CLEC14A as a therapeutic target in solid tumours
by: Joseph Robinson, et al.
Published: (2020-10-01) -
The role of CLEC2-CLEC5A/TLR2 axis in influenza infection
by: Yi-An Chen, et al.
Published: (2019) -
CLEC2 and CLEC5A: Pathogenic Host Factors in Acute Viral Infections
by: Pei-Shan Sung, et al.
Published: (2019-12-01) -
Platelet CLEC‐2 and lung development
by: Katsue Suzuki‐Inoue, et al.
Published: (2020-05-01)